PPFIBP1 Antibody

What is PPFIBP1 and what cellular functions does it regulate?

PPFIBP1, also known as liprin-beta-1, functions as a key player in signaling pathways controlling cell growth and development. This protein is involved in regulating cell proliferation and differentiation processes and may play a significant role in focal adhesion dynamics. PPFIBP1 is a member of the LAR protein-tyrosine phosphatase-interacting protein (liprin) family and is particularly known for its regulatory role in the disassembly of focal adhesions . It has been established that PPFIBP1 did not bind receptor-like tyrosine phosphatases type 2A, which provides insights into its selectivity in protein-protein interactions . Understanding these fundamental properties is essential before designing experiments with PPFIBP1 antibodies.

What is the molecular structure and cellular localization of PPFIBP1?

PPFIBP1 is a 114 kDa protein with complex subcellular distribution patterns. The protein has been detected in multiple cellular compartments including the cytosol, plasma membrane, and notably, the presynaptic active zone . This diverse localization reflects its multifunctional role in cellular processes. The sequence of human PPFIBP1 used for antibody generation often includes amino acids 846-1005 (NP_003613.3), particularly for polyclonal antibody production . When designing immunolocalization experiments, researchers should account for this diverse distribution pattern across different cellular compartments.

What synonyms and identifiers are used for PPFIBP1 in scientific literature?

PPFIBP1 appears in scientific databases and literature under multiple names, which can complicate literature searches. Common synonyms include:

• L2

• SGT2

• hSGT2

• hSgt2p

• NEDSMBA

• KIAA1230

• Liprin-beta-1

• Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1

• PTPRF-interacting protein-binding protein 1

Researchers should use multiple identifiers when conducting comprehensive literature reviews to ensure all relevant studies are captured.

What types of PPFIBP1 antibodies are currently available for research?

Current research primarily utilizes polyclonal antibodies against PPFIBP1. Rabbit polyclonal antibodies, such as CAB16456 and ab195339, have been well-characterized and validated for multiple applications . The advantage of these polyclonal preparations is their ability to recognize multiple epitopes on the PPFIBP1 protein, potentially increasing detection sensitivity. According to available data, there appear to be at least 11 total PPFIBP1 antibody products from 5 different suppliers, offering researchers various options depending on their specific experimental needs .

How should researchers validate PPFIBP1 antibodies before experimental use?

Proper validation of PPFIBP1 antibodies is essential for generating reliable results. A robust validation protocol should include:

• Positive control testing: Use known positive samples such as A-375 cells, HeLa cells, or mouse liver tissue, which have been confirmed to express PPFIBP1 .

• Western blot validation: Confirm antibody specificity by detecting a band at approximately 114 kDa, which corresponds to the calculated molecular weight of PPFIBP1 .

• Cross-reactivity assessment: Evaluate antibody performance across multiple species if working with non-human models. Current antibodies show reactivity with human, mouse, and rat samples .

• Knockout/knockdown controls: When possible, include PPFIBP1 knockdown samples to confirm specificity of the antibody signal.

• Dilution optimization: Test multiple antibody dilutions to determine optimal working concentrations (typical recommended dilutions for Western blot applications range from 1:500 to 1:2000) .

What are the optimal protocols for using PPFIBP1 antibodies in Western blot applications?

For Western blot applications using PPFIBP1 antibodies, researchers should follow these optimized protocols:

• Sample preparation: Prepare protein lysates from tissues or cells known to express PPFIBP1 (e.g., A-375, HeLa, or mouse liver) .

• Protein loading: Load 20-50 μg of total protein per lane.

• Antibody dilution: Use the recommended dilution range of 1:500 to 1:2000 for primary antibody incubation . Optimal dilution should be determined empirically for each experimental system.

• Incubation conditions: Incubate membranes with primary antibody overnight at 4°C for best results.

• Detection system: Use an appropriate secondary antibody conjugated to HRP or fluorescent dye compatible with rabbit IgG.

• Expected results: Look for a specific band at approximately 114 kDa, which corresponds to the observed molecular weight of PPFIBP1 .

Can PPFIBP1 antibodies be used for immunoprecipitation studies?

Yes, certain PPFIBP1 antibodies have been validated for immunoprecipitation (IP) applications. For example, the antibody ab195339 is reported to be suitable for IP experiments . When performing IP with PPFIBP1 antibodies:

• Use 2-5 μg of antibody per 500 μg of protein lysate.

• Include appropriate negative controls (non-immune IgG from the same species).

• Confirm precipitated protein via Western blot using a different PPFIBP1 antibody if possible.

• Consider pre-clearing lysates to reduce non-specific binding.

This approach is particularly valuable for studying PPFIBP1 protein interactions and post-translational modifications.

What sample types have been validated for PPFIBP1 antibody applications?

Several sample types have been validated for use with PPFIBP1 antibodies:

• Cell lines: A-375 and HeLa cells have been confirmed as positive samples for PPFIBP1 detection .

• Tissue samples: Mouse liver has been validated as a positive control tissue .

• Species reactivity: Current antibodies demonstrate cross-reactivity with human, mouse, and rat samples .

Researchers working with other cell lines or tissues should perform preliminary validation studies to confirm PPFIBP1 expression and antibody reactivity in their specific experimental systems.

How can PPFIBP1 antibodies be used to study focal adhesion dynamics?

PPFIBP1 has been implicated in regulating the disassembly of focal adhesions , making it an important target for studying cell adhesion and migration. Researchers can utilize PPFIBP1 antibodies to:

• Track spatial dynamics: Employ immunofluorescence techniques to visualize PPFIBP1 localization during focal adhesion assembly and disassembly.

• Identify interaction partners: Use co-immunoprecipitation with PPFIBP1 antibodies to pull down and identify protein complexes involved in focal adhesion regulation.

• Assess phosphorylation states: Combine PPFIBP1 antibodies with phospho-specific antibodies to monitor how phosphorylation affects PPFIBP1 function in focal adhesion dynamics.

• Knockdown studies: Utilize PPFIBP1 antibodies to confirm successful protein knockdown in siRNA experiments studying focal adhesion turnover.

These approaches can provide valuable insights into PPFIBP1's role in cell migration, invasion, and tissue remodeling processes.

What is known about PPFIBP1's role in the presynaptic active zone?

PPFIBP1 has been localized to the presynaptic active zone , suggesting potential roles in neuronal function and synaptic transmission. Researchers investigating these functions can:

• Perform co-localization studies: Use PPFIBP1 antibodies alongside markers for presynaptic active zone components to map spatial relationships.

• Conduct fractionation studies: Employ subcellular fractionation followed by Western blot with PPFIBP1 antibodies to confirm enrichment in synaptic fractions.

• Investigate protein interactions: Use proximity ligation assays with PPFIBP1 antibodies to identify nearby interaction partners specifically at the presynaptic active zone.

• Study activity-dependent changes: Monitor PPFIBP1 localization and post-translational modifications following neuronal stimulation protocols.

This research direction could significantly advance our understanding of synapse organization and function.

Why might researchers observe multiple bands when using PPFIBP1 antibodies in Western blot?

Multiple bands in Western blot experiments using PPFIBP1 antibodies may result from several factors:

• Protein isoforms: PPFIBP1 may exist in multiple splice variants or isoforms that are detected by the antibody.

• Post-translational modifications: Phosphorylation, glycosylation, or other modifications can alter protein migration.

• Proteolytic degradation: Sample preparation methods may result in partial protein degradation, generating fragments recognized by the antibody.

• Non-specific binding: Especially with polyclonal antibodies, cross-reactivity with related proteins may occur.

To address this issue, researchers should:

• Compare observed band patterns with the expected molecular weight (114 kDa)

• Include appropriate positive controls (A-375, HeLa cells, mouse liver)

• Optimize antibody dilution (1:500-1:2000 for Western blot)

• Consider using protein samples from PPFIBP1 knockdown experiments as negative controls

How can researchers interpret conflicting data from different PPFIBP1 antibodies?

When confronted with conflicting results from different PPFIBP1 antibodies, researchers should consider:

• Epitope differences: Different antibodies target distinct regions of the PPFIBP1 protein. For example, ab195339 targets a synthetic peptide within amino acids 150-250 , while CAB16456 recognizes amino acids 846-1005 . These epitopes may be differentially accessible depending on protein conformation, interactions, or modifications.

• Antibody validation: Review validation data for each antibody, including Western blot images, positive controls used, and recommended applications.

• Experimental conditions: Variations in sample preparation, buffer composition, or detection methods may affect antibody performance.

• Cross-validation approaches: When possible, employ complementary techniques (e.g., mass spectrometry) to resolve discrepancies and confirm protein identity.

A systematic approach to reconciling conflicting data can turn a potential experimental problem into an opportunity for deeper mechanistic insights.

How might antibody-based approaches contribute to understanding PPFIBP1 in disease contexts?

PPFIBP1 has potential implications in diseases such as cancer and developmental disorders . Antibody-based approaches can advance our understanding of these connections through:

• Tissue microarray analysis: Using PPFIBP1 antibodies to screen diverse patient samples can reveal expression patterns associated with specific disease states or prognostic outcomes.

• Functional studies: Combining PPFIBP1 antibodies with cell-based assays can elucidate how alterations in this protein contribute to pathological cell behaviors.

• Biomarker development: Evaluating PPFIBP1 as a potential diagnostic or prognostic marker using validated antibodies in patient samples.

• Therapeutic target validation: Antibodies can help confirm the accessibility and expression of PPFIBP1 in relevant disease contexts before therapeutic development.

These approaches may ultimately contribute to identifying new therapeutic targets and improving treatment strategies for various diseases where PPFIBP1 plays a role.

What methodological approaches can be used to study interactions between PPFIBP1 and other signaling proteins?

Understanding PPFIBP1's interactions with other proteins is crucial for elucidating its functional roles. Researchers can employ several antibody-dependent methods:

• Co-immunoprecipitation: Using PPFIBP1 antibodies to pull down protein complexes, followed by mass spectrometry or Western blot analysis to identify interaction partners.

• Proximity ligation assays: Combining PPFIBP1 antibodies with antibodies against suspected interaction partners to visualize and quantify protein-protein interactions in situ.

• FRET/BRET analysis: Using antibodies to validate interaction partners identified through fluorescence or bioluminescence resonance energy transfer approaches.

• Pull-down assays: Employing purified PPFIBP1 domains as bait, followed by antibody detection of captured proteins.

These methodologies can reveal both stable and transient interactions, providing insights into PPFIBP1's role in signaling networks and cellular processes.